跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAGESIL 75 MG/3 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DAGESIL 75 MG/3 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG
Approved
STANDARD
DAGESIL 75 MG/3 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG
Laboratorios Basi Industria Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 9, 2023
Approval ID
b3a64f565c6c270e
Company
Laboratorios Basi Industria Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
b3a64f565c6c270e
Drug Cima Aemps Name
DAGESIL 75 MG/3 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG
Register Number
89081
Holder Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Marketing Company Name
Laphysan S.A.U.
Authorization Date
2023-10-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
75 mg/3 ml
Route Of Administration
VÍA INTRAMUSCULAR, VÍA INTRAVENOSA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Active Ingredients
DICLOFENACO SODICO
75 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 9, 2023
Approval ID
b3a64f565c6c270e
Type
Standard
Back to CIMA-AEMPS Approvals